Is it Time to Dump LENSAR Inc (LNSR) Stock After it Is Up 26.58% in a Week?

LENSAR Inc (LNSR) stock has risen 26.58% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

LENSAR Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on LNSR!

See Full LNSR Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With LNSR Stock Today?

LENSAR Inc (LNSR) stock is up 8.3% while the S&P 500 has fallen -0.77% as of 4:00 PM on Wednesday, May 24. LNSR is higher by $0.23 from the previous closing price of $2.77 on volume of 97,079 shares. Over the past year the S&P 500 has risen 3.52% while LNSR has fallen -58.68%. LNSR lost -$1.70 per share in the over the last 12 months.

More About LENSAR Inc

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit. Click Here to get the full Stock Report for LENSAR Inc stock.